Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Choosing the right accounts—taxable, tax-advantaged, or retirement—can significantly reduce taxes on index fund gains and distributions.
25,988 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
This year brought a sharp retreat in Accenture’s stock. The drop isn’t just a price move—it's a signal. This guide br...
With mortgage rates persisting at elevated levels, lenders are testing fresh ways to keep homebuyers in the market. A...
Intel leads a high-stakes comeback race among legacy hardware players, while HP and Xerox wrestle with structural hea...
A new wave of headlines around Nebius stock is stirring debate among investors. This guide breaks down what the news ...
Could a Palantir competitor deliver the kind of upside that fans of AI software chase? This article breaks down the c...
New data shows many Americans over 50 have under 50k saved for retirement, highlighting a growing gap between savings...
As AI accelerates, the question for investors is clear: will Verisk's valuable data keep its edge or fade into a sea ...
Palantir faced a sharp 34% drop in the first half of 2026 as AI market expectations and earnings jitters weighed on s...
Travel trends shifting—here’s it’s changing where guests stay, how long they visit, and what hosts can charge. This g...
Boeing appointed Kelly Ortberg as CEO in August 2024 to launch an inside-out turnaround. The plan focuses on quality,...
Is Micron stock under a lofty price point worth buying? This article breaks down the key factors, including memory ma...